Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation
接受氟达拉滨、阿糖胞苷和安吖啶联合治疗后，进行减低强度预处理和异基因造血干细胞移植的难治性急性髓系白血病患者预后风险因素
期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-015-2050-y
Pfrepper, Christian; Klink, Anne; Behre, Gerhard; Schenk, Thomas; Franke, Georg-Nikolaus; Jentzsch, Madlen; Schwind, Sebastian; Al-Ali, Haifa-Kathrin; Hochhaus, Andreas; Niederwieser, Dietger; Sayer, Herbert Gottfried
